X4 Pharmaceuticals Inc (XFOR)
1.05
-0.02
(-1.41%)
USD |
NASDAQ |
May 10, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Free Cash Flow (Quarterly): -33.66M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -33.66M |
| December 31, 2023 | -27.78M |
| September 30, 2023 | -20.84M |
| June 30, 2023 | -21.43M |
| March 31, 2023 | -26.52M |
| December 31, 2022 | -19.13M |
| September 30, 2022 | -19.32M |
| June 30, 2022 | -18.51M |
| March 31, 2022 | -20.25M |
| December 31, 2021 | -19.07M |
| September 30, 2021 | -14.23M |
| June 30, 2021 | -19.28M |
| March 31, 2021 | -18.94M |
| December 31, 2020 | -17.81M |
| September 30, 2020 | -14.82M |
| Date | Value |
|---|---|
| June 30, 2020 | -11.47M |
| March 31, 2020 | -16.08M |
| December 31, 2019 | -9.324M |
| September 30, 2019 | -12.85M |
| June 30, 2019 | -14.30M |
| March 31, 2019 | -11.75M |
| December 31, 2018 | 8.431M |
| September 30, 2018 | -8.167M |
| June 30, 2018 | -13.51M |
| March 31, 2018 | -12.18M |
| December 31, 2017 | -12.89M |
| September 30, 2017 | -5.108M |
| June 30, 2017 | -6.387M |
| March 31, 2017 | -3.528M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-33.66M
Minimum
Mar 2024
-9.324M
Maximum
Dec 2019
-18.78M
Average
-19.00M
Median
Free Cash Flow (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp | -2.37M |
| Ocular Therapeutix Inc | -34.14M |
| Alpine Immune Sciences Inc | -19.08M |
| Scholar Rock Holding Corp | -49.81M |
| RAPT Therapeutics Inc | -27.19M |